Biochemical and biophysical mechanisms macrophages use to tune phagocytic appetite
- PMID: 39749603
- PMCID: PMC11828473
- DOI: 10.1242/jcs.263513
Biochemical and biophysical mechanisms macrophages use to tune phagocytic appetite
Abstract
Macrophages phagocytose, or eat, pathogens, dead cells and cancer cells. To activate phagocytosis, macrophages recognize 'eat me' signals like IgG and phosphatidylserine on the target cell surface. Macrophages must carefully adjust their phagocytic appetite to ignore non-specific or transient eat me signal exposure on healthy cells while still rapidly recognizing pathogens and debris. Depending on the context, macrophages can increase their appetite for phagocytosis, to prioritize an effective immune response, or decrease their appetite, to avoid damage to healthy tissue during homeostasis. In this Review, we discuss the biochemical and biophysical mechanisms that macrophages employ to increase or decrease their sensitivity or capacity for phagocytosis. We discuss evidence that macrophages tune their sensitivity via several mechanisms, including altering the balance of activating and inhibitory receptor expression, altering the availability of activating receptors, as well as influencing their clustering and mobility, and modulating inhibitory receptor location. We also highlight how membrane availability limits the capacity of macrophages for phagocytosis and discuss potential mechanisms to promote membrane recycling and increase phagocytic capacity. Overall, this Review highlights recent work detailing the molecular toolkit that macrophages use to alter their appetite.
Keywords: ADCP; Efferocytosis; IgG; Macrophage; Phagocytic Appetite; Phagocytosis.
© 2025. Published by The Company of Biologists.
Conflict of interest statement
Competing interests The authors declare no competing or financial interests.
Figures
References
-
- Bailey, E. M., Choudhury, A., Vuppula, H., Ortiz, D. F., Schaeck, J., Manning, A. M., Bosques, C. J. and Hoppe, A. D. (2020). Engineered IgG1-Fc molecules define valency control of cell surface Fcγ receptor inhibition and activation in endosomes. Front. Immunol. 11, 617767. 10.3389/fimmu.2020.617767 - DOI - PMC - PubMed
-
- Barkal, A. A., Brewer, R. E., Markovic, M., Kowarsky, M., Barkal, S. A., Zaro, B. W., Krishnan, V., Hatakeyama, J., Dorigo, O., Barkal, L. J.et al. (2019). CD24 signalling through macrophage Siglec-10 is a new target for cancer immunotherapy. Nature 572, 392-396. 10.1038/s41586-019-1456-0 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
